Latest Clinical Device Commercialisation News

Page 1 of 1

Optiscan Launches InSpecta™ in US Veterinary Market After FDA Approval

Optiscan Imaging has begun commercial sales of its InSpecta™ microscopic imaging device in the US veterinary sector following FDA clearance, marking its first clinical device launch and a strategic expansion into a $15.87 billion market.

Ada Torres

7 July 2026

Top